RetinalGenix Technologies (RTGN) Preferred Shares (2020 - 2021)
RetinalGenix Technologies (RTGN) reported Preferred Shares of $300.0 for Q3 2021, little changed sequentially from $300.0 in Q4 2020.
RetinalGenix Technologies (RTGN) Preferred Shares (2020 - 2021) Analysis & Trends
RetinalGenix Technologies (RTGN) has 2 years of Preferred Shares data on file, last reported at $300.0 in Q3 2021.
- For the quarter ending Q3 2021, Preferred Shares changed N/A year-over-year to $300.0; the trailing twelve-month figure through Sep 2021 stood at $300.0 (changed N/A YoY), and the FY2020 full-year result was $300.0, changed N/A from the prior year.
- Preferred Shares held at $300.0 in Q3 2021, from $300.0 in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $300.0 in Q4 2020 to a low of $300.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.94 Bn | 126.06 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.65 Bn | 67.19 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.10 Bn | 21.98 Bn | 2.07 Bn | - |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 300.00 |
| Dec 31, 2020 | 300.00 |